- Home
- DFH vs TLRY Comparison
DFH vs TLRY Comparison
Compare DFH & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DFH | TLRY |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DFH | TLRY |
|---|---|---|
| Price | $19.69 | $11.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $26.00 | ★ $150.00 |
| AVG Volume (30 Days) | 342.9K | ★ 9.5M |
| Earning Date | 10-30-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $4,671,814,000.00 | $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $1.86 | $4.51 |
| P/E Ratio | $7.00 | ★ N/A |
| Revenue Growth | ★ 15.98 | 2.31 |
| 52 Week Low | $17.61 | $3.51 |
| 52 Week High | $31.50 | $23.20 |
Technical Indicators
Market Signals| Indicator | DFH | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 86.25 |
| Support Level | $19.51 | $7.10 |
| Resistance Level | $20.16 | $8.64 |
| Average True Range (ATR) | 0.73 | 0.73 |
| MACD | 0.23 | 0.78 |
| Stochastic Oscillator | 73.15 | 90.74 |
Price Performance
Historical ComparisonAbout DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.